مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
Normal view MARC view ISBD view

VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. [electronic resource]

By:
  • Delain, M
Contributor(s):
  • Linassier, C
  • Petitdidier, C
  • Goupille, P
  • Luthier, F
  • Combe, M
  • Reisenleiter, M
  • Benboubker, L
  • Lamagnère, J P
  • Colombat, P
Producer: 19950112Description: 2706-13 p. digitalISSN:
  • 0732-183X
Subject(s):
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols -- adverse effects
  • Carmustine -- administration & dosage
  • Cyclophosphamide -- administration & dosage
  • Dexamethasone -- administration & dosage
  • Doxorubicin -- administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma -- drug therapy
  • Neoplasm Staging
  • Prednisone -- administration & dosage
  • Prognosis
  • Prospective Studies
  • Regression Analysis
  • Survival Analysis
  • Treatment Outcome
  • Vincristine -- administration & dosage
  • Vindesine -- administration & dosage
Online resources:
  • Available from publisher's website
In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Clinical Trial; Journal Article; Multicenter Study

There are no comments on this title.

Log in to your account to post a comment.

VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.

APA

Delain M., Linassier C., Petitdidier C., Goupille P., Luthier F., Combe M., Reisenleiter M., Benboubker L., Lamagnère J. P. & Colombat P. (19950112). VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Delain M, Linassier C, Petitdidier C, Goupille P, Luthier F, Combe M, Reisenleiter M, Benboubker L, Lamagnère J P and Colombat P. 19950112. VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Delain M., Linassier C., Petitdidier C., Goupille P., Luthier F., Combe M., Reisenleiter M., Benboubker L., Lamagnère J. P. and Colombat P. (19950112). VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Delain M, Linassier C, Petitdidier C, Goupille P, Luthier F, Combe M, Reisenleiter M, Benboubker L, Lamagnère J P and Colombat P. VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19950112.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site